Interstitial macrophages in cigarette smoke-induced small airway remodeling

间质巨噬细胞在香烟烟雾诱导的小气道重塑中的作用

基本信息

  • 批准号:
    10540350
  • 负责人:
  • 金额:
    $ 15.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Project Summary: This proposal describes a 5-year research training program that will develop Dr. Patrick Hume into an independent basic and translational physician-scientist investigator. His long-term career goal is to advance the fields of COPD and macrophage biology through the elucidation targets to block or repair the development of small-airways disease in cigarette smokers. During this K08 Award, Dr. Hume will gain specific career development training and mentorship closely aligned with an innovative research plan. He proposes to study the role of Lyve-1 positive interstitial macrophages in the development of small airway pathology induced by chronic cigarette smoke. Given the broad applicability to COPD, this work is directly relevant to the NHLBI. Candidate: Patrick Human MD, PhD is a board-certified Pulmonary and Critical Care Medicine physician- scientist at National Jewish Health in Denver, CO. His record of basic science research, Ph.D. training and scientific publications demonstrates a firm commitment to a career as an academic clinician-scientist. Training: The proposed career development plan augments Dr. Hume’s prior mentored research during his undergraduate, doctoral, medical residency and fellowship training. He proposes to meet his short-term objectives through an integrated combination of intensive mentoring by internationally renowned experts in macrophage biology and COPD pathogenesis with didactic and hands-on experiences in (i) data analysis, (ii) cell biology, (iii) hyaluronic acid signaling, (iv) scientific writing and presentation, and (v) laboratory leadership. Mentor / Environment: Dr. Hume has close working relationships with highly experienced mentors and collaborators who contribute expertise in macrophage and lung biology (Drs. Janssen and Petrache), COPD pathogenesis and hyaluronic acid signaling (Dr. Petrache), matrix metalloproteinase biology and tissue remodeling (Dr. Redente), creation of transgenic mouse models (Dr. Matsuda) and design-based stereology (Dr. Smith). The proposed activities will be based at National Jewish Health, a top-ranked research institution. Research Project: The primary objective of this proposal is to identify the mechanism by which peribronchial interstitial macrophages (PBIMs) mediate airway wall remodeling and pathogenesis in response to chronic cigarette smoke exposure. Specifically, our studies will test the hypothesis that Lyve-1 expressed on a subset of PBIMs binds to hyaluronic acid resulting in matrix metalloproteinase 9 (MMP-9) production, leading to airway wall remodeling and fibrosis. This will be tested in human and murine lung tissue using quantitative morphometry and immunofluorescence, flow cytometry, in vitro models of hyaluronic acid signaling, and transgenic animal models. In doing so, the specific relationships between Lyve-1+ PBIM recruitment, MMP-9 production, and airway wall remodeling will be elucidated.
项目摘要 项目概要:该提案描述了一个为期5年的研究培训计划,将培养帕特里克博士 休谟成为一个独立的基础和翻译的医生科学家调查。他的长期职业目标是 通过阐明靶点来阻断或修复慢性阻塞性肺病和巨噬细胞生物学领域, 吸烟者小气道疾病的发展。在K 08奖期间,休姆博士将获得具体的 职业发展培训和导师制与创新研究计划紧密结合。他拟 研究Lyve-1阳性间质巨噬细胞在小气道病变中的作用 慢性吸烟的危害鉴于对COPD的广泛适用性,这项工作与NHLBI直接相关。 候选人:帕特里克人类医学博士,博士是一个委员会认证的肺和重症监护医学医生- 科学家在国家犹太人健康在丹佛,公司。培训和 科学出版物表明了坚定的承诺,作为一个学术临床科学家的职业生涯。 培训:拟议的职业发展计划增强了Hume博士在其职业生涯中的前期指导研究。 本科生、博士生、住院医师和研究员培训。他建议满足他的短期 通过国际知名专家的密集指导, 巨噬细胞生物学和COPD发病机制,在(i)数据分析,(ii) 细胞生物学,(iii)透明质酸信号传导,(iv)科学写作和演示,以及(v)实验室领导。 导师/环境:Hume博士与经验丰富的导师有着密切的工作关系, 在巨噬细胞和肺生物学方面贡献专业知识的合作者(Janssen和Petrache博士),COPD 发病机制和透明质酸信号传导(Petrache博士),基质金属蛋白酶生物学和组织 重塑(Redente博士),创建转基因小鼠模型(Matsuda博士)和基于设计的体视学 (Dr.史密斯)。拟议的活动将设在国家犹太健康,一个顶级的研究机构。 研究项目:该提案的主要目的是确定支气管周围 间质性巨噬细胞(PBIM)介导气道壁重塑和慢性炎症反应的发病机制 香烟烟雾暴露。具体来说,我们的研究将检验Lyve-1在一个子集上表达的假设, 的PBIM与透明质酸结合,导致基质金属蛋白酶9(MMP-9)的产生,导致气道炎症。 壁重塑和纤维化。这将在人和鼠肺组织中进行测试,使用定量 形态测定和免疫荧光,流式细胞术,透明质酸信号传导的体外模型, 转基因动物模型在这样做时,Lyve-1+ PBIM募集、MMP-9和MMP-10之间的特定关系可以被解释为: 产生和气道壁重塑将被阐明。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick Scott Hume其他文献

Patrick Scott Hume的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick Scott Hume', 18)}}的其他基金

Interstitial macrophages in cigarette smoke-induced small airway remodeling
间质巨噬细胞在香烟烟雾诱导的小气道重塑中的作用
  • 批准号:
    10370226
  • 财政年份:
    2022
  • 资助金额:
    $ 15.83万
  • 项目类别:

相似海外基金

EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center
气道疾病暴露组分析以解开哮喘疾病的决定因素 (EXPAND-Asthma) 中心
  • 批准号:
    10744673
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
噬菌体作为慢性假单胞菌气道疾病的预测生物标志物
  • 批准号:
    10723956
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
定义气道疾病、COPD 恶化和治疗反应的基因表达特征
  • 批准号:
    10733573
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease
母亲砷暴露对后代过敏性气道疾病表观遗传重编程的影响
  • 批准号:
    10733607
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
Hydrogen Sulfide in Neonatal Airway Disease
新生儿气道疾病中的硫化氢
  • 批准号:
    10603293
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
Immune Mediators of IL-22 Signaling Alter Allergic Airway Disease
IL-22 信号的免疫介质改变过敏性气道疾病
  • 批准号:
    10853347
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
  • 批准号:
    10716654
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress
假单胞菌脂质 A 结构在 CF 气道疾病进展中的微生物适应
  • 批准号:
    10722599
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
  • 批准号:
    10985906
  • 财政年份:
    2023
  • 资助金额:
    $ 15.83万
  • 项目类别:
Mentoring patient-oriented researchers in inflammatory airway disease
指导炎症性气道疾病领域以患者为中心的研究人员
  • 批准号:
    10657746
  • 财政年份:
    2022
  • 资助金额:
    $ 15.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了